Related Experiment Videos
[Biochemical bases and research in attention-deficit hyperactivity disorder]
1Neuropediatric Unit, Department of Womand and Child Health, Astrid Lindgren Children Hospital, Karolinska Institutet, Stockholm, Sweden. Rochellys.Heijtz@home.se
Revista De Neurologia
|November 26, 2002
Summary
Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder. Recent studies reveal neurobiological underpinnings involving frontal striatal circuits and neurotransmitter dysregulation, offering insights into ADHD treatment.
Area of Science:
- Neuroscience
- Psychiatry
Context:
- Attention deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder affecting school-aged children, characterized by inattention, hyperactivity, and impulsivity.
- ADHD presents with significant comorbidity risks and potential long-term cognitive, emotional, and social impairments.
Purpose:
- To review recent advancements in understanding the neurobiological basis of ADHD.
- To explore the neurobiological underpinnings of ADHD, including neuroimaging findings and neurotransmitter system involvement.
Summary:
- Neuroimaging studies indicate frontal striatal circuit dysfunction in ADHD patients, responsive to pharmacological treatment.
- Evidence suggests dysregulation in dopaminergic and noradrenergic systems contributes to ADHD.
- Emerging research links ADHD features to alterations in the posterior inferior vermis.
Impact:
- Findings highlight the role of specific brain circuits and neurotransmitter systems in ADHD pathophysiology.
- Understanding the neurobiological basis can inform and improve ADHD diagnosis and treatment strategies.
- Consideration of factors like age, gender, and treatment duration is crucial for interpreting ADHD research findings.